Applying Machine Learning to Evaluate for Fibrosis in Chronic Hepatitis C
View ORCID ProfileAravind Akella, View ORCID ProfileSudheer Akella
doi: https://doi.org/10.1101/2020.11.02.20224840
Aravind Akella
Qualicel Global Inc., Huntington Station, NY 11746
Sudheer Akella
Qualicel Global Inc., Huntington Station, NY 11746
Posted November 04, 2020.
Applying Machine Learning to Evaluate for Fibrosis in Chronic Hepatitis C
Aravind Akella, Sudheer Akella
medRxiv 2020.11.02.20224840; doi: https://doi.org/10.1101/2020.11.02.20224840
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (676)
- Anesthesia (182)
- Cardiovascular Medicine (2676)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12304)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4149)
- Geriatric Medicine (389)
- Health Economics (684)
- Health Informatics (2688)
- Health Policy (1009)
- Hematology (365)
- HIV/AIDS (859)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2068)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (252)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1128)
- Primary Care Research (461)
- Public and Global Health (6572)
- Radiology and Imaging (1418)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)